Ashley Ivor Simon Morris
Nessuna posizione attualmente
Storia della carriera di Ashley Ivor Simon Morris
Precedenti posizioni note di Ashley Ivor Simon Morris
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SCIGEN LIMITED | Direttore/Membro del Consiglio | 14/02/2017 | 08/09/2017 |
| Amministratore Delegato | 09/02/2017 | 08/09/2017 | |
| MERCK SHARP DOHME PHARMA TBK PT | Corporate Officer/Principal | 01/01/2004 | 01/01/2009 |
Formazione di Ashley Ivor Simon Morris
| The University of Nottingham | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Singapore | 2 |
| Regno Unito | 2 |
| Indonesia | 2 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERCK SHARP DOHME PHARMA TBK PT | Health Technology |
| Aziende private | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
